Equasens SA
PAR:EQS

Watchlist Manager
Equasens SA Logo
Equasens SA
PAR:EQS
Watchlist
Price: 43.25 EUR 0.12% Market Closed
Market Cap: 650.1m EUR
Have any thoughts about
Equasens SA?
Write Note
Section:
 

Relative Value

The Relative Value of one EQS stock under the Base Case scenario is 76.09 EUR. Compared to the current market price of 43.25 EUR, Equasens SA is Undervalued by 43%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EQS Relative Value
Base Case
76.09 EUR
Undervaluation 43%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3
P/S
P/S
Price to Sales
3
vs History
93
vs Industry
35
Median 3Y
5
Median 5Y
5.6
Industry
2.3
Forward
2.9
More Details
13.8
P/E
P/E
Price to Earnings
13.8
vs History
93
vs Industry
32
Median 3Y
23.2
Median 5Y
28
Industry
23.1
Forward
16.2
More Details
11.3
P/OCF
P/OCF
Price to OCF
11.3
vs History
92
vs Industry
29
Median 3Y
18
Median 5Y
22.4
Industry
14.2
More Details
15.8
P/FCFE
P/FCFE
Price to FCFE
15.8
vs History
92
vs Industry
25
Median 3Y
22.5
Median 5Y
26.5
Industry
20.1
More Details
3
P/B
P/B
Price to Book Value
3
vs History
93
vs Industry
24
Median 3Y
5.7
Median 5Y
6.9
Industry
2.2
More Details
2.9
EV/S
EV/S
Enterprise Value to Sales
2.9
vs History
93
vs Industry
34
Median 3Y
4.9
Median 5Y
5.5
Industry
2.4
Forward
2.8
More Details
4.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.2
vs History
93
vs Industry
43
Median 3Y
7.2
Median 5Y
8.1
Industry
5
More Details
9.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
9.3
vs History
93
vs Industry
31
Median 3Y
15.2
Median 5Y
17.6
Industry
12.7
Forward
11.4
More Details
11.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
11.6
vs History
93
vs Industry
32
Median 3Y
19.1
Median 5Y
21.4
Industry
17.1
Forward
15.4
More Details
11.1
EV/OCF
EV/OCF
Enterprise Value to OCF
11.1
vs History
92
vs Industry
30
Median 3Y
17.4
Median 5Y
21.8
Industry
14
More Details
16.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
16.3
vs History
90
vs Industry
24
Median 3Y
22.5
Median 5Y
29.3
Industry
18
More Details
2
EV/IC
EV/IC
Enterprise Value to IC
2
vs History
93
vs Industry
34
Median 3Y
4
Median 5Y
4.5
Industry
1.9
More Details

Multiples Across Competitors

EQS Competitors Multiples
Equasens SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Equasens SA
PAR:EQS
650.1m EUR 3 13.8 9.3 11.6
US
Veeva Systems Inc
NYSE:VEEV
36.3B USD 13.7 54.6 46.3 49
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
26.3B AUD 158.2 317.8 222.4 222.4
US
Doximity Inc
NYSE:DOCS
10.8B USD 20.9 62 47.1 49.5
US
Waystar Holding Corp
NASDAQ:WAY
6.3B USD 7 -120.4 24.7 68.7
JP
M3 Inc
TSE:2413
927.2B JPY 3.7 23.7 11.7 13.7
US
Inspire Medical Systems Inc
NYSE:INSP
5.6B USD 7.4 170.2 283.7 386.4
SE
Sectra AB
STO:SECT B
52.8B SEK 29.2 118.1 -70.6 -70.6
US
Vocera Communications Inc
F:V00
2.4B EUR 10.7 -294.8 239.5 3 835.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
17B CNY 5.4 47.2 33.9 33.9
P/E Multiple
Earnings Growth P/E to Growth
FR
Equasens SA
PAR:EQS
Average P/E: 95.6
13.8
28%
0.5
US
Veeva Systems Inc
NYSE:VEEV
54.6
142%
0.4
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
317.8
131%
2.4
US
Doximity Inc
NYSE:DOCS
62
78%
0.8
US
W
Waystar Holding Corp
NASDAQ:WAY
Negative Multiple: -120.4 N/A N/A
JP
M3 Inc
TSE:2413
23.7
33%
0.7
US
Inspire Medical Systems Inc
NYSE:INSP
170.2
N/A N/A
SE
Sectra AB
STO:SECT B
118.1
81%
1.5
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -294.8 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
47.2
142%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Equasens SA
PAR:EQS
Average EV/EBITDA: 94
9.3
30%
0.3
US
Veeva Systems Inc
NYSE:VEEV
46.3
221%
0.2
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
222.4
130%
1.7
US
Doximity Inc
NYSE:DOCS
47.1
92%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
24.7
N/A N/A
JP
M3 Inc
TSE:2413
11.7
24%
0.5
US
Inspire Medical Systems Inc
NYSE:INSP
283.7
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -70.6 N/A N/A
US
V
Vocera Communications Inc
F:V00
239.5
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
33.9
143%
0.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Equasens SA
PAR:EQS
Average EV/EBIT: 471.4
11.6
32%
0.4
US
Veeva Systems Inc
NYSE:VEEV
49
239%
0.2
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
222.4
122%
1.8
US
Doximity Inc
NYSE:DOCS
49.5
102%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
68.7
N/A N/A
JP
M3 Inc
TSE:2413
13.7
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
386.4
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -70.6 N/A N/A
US
V
Vocera Communications Inc
F:V00
3 835.2
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
33.9
123%
0.3

See Also

Summary
EQS intrinsic value, competitors valuation, and company profile.
DCF Valuation
EQS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EQS stock valuation using valuation multiples.
Wall Street Estimates
EQS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EQS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.